CA Patent

CA1331757C — 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols

Assigned to Janssen Pharmaceutica NV · Expires 1994-08-30 · 32y expired

What this patent protects

ABSTRACT 5-LIPOXYGENASE INHIBITING 4-(4-PHENYL-1-PIPERAZINYL)PHENOLS 4-(4-phenyl-1-piperazinyl)phenols for use as 5-lipoxygenase inhibitors and a method of treating warm-blooded animals suffering from leukotriene mediated diseases and disorders using the same. Pharmaceutica…

USPTO Abstract

ABSTRACT 5-LIPOXYGENASE INHIBITING 4-(4-PHENYL-1-PIPERAZINYL)PHENOLS 4-(4-phenyl-1-piperazinyl)phenols for use as 5-lipoxygenase inhibitors and a method of treating warm-blooded animals suffering from leukotriene mediated diseases and disorders using the same. Pharmaceutical compositions containing the same asactive ingredient. Novel compounds used in said method and processes for preparing said novel compounds.

Drugs covered by this patent

Patent Metadata

Patent number
CA1331757C
Jurisdiction
CA
Classification
—
Expires
1994-08-30
Drug substance claim
No
Drug product claim
No
Assignee
Janssen Pharmaceutica NV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.